The Centers for Disease Control and Prevention (CDC) is warning of a potential outbreak of an extensively drug-resistant bacteria in eye drops. The bacteria, which is linked to New York and New Jersey, has been found in the EzriCare eye drops manufactured in India.

The CDC is currently investigating the matter after reports of dozens of infections and one death in 11 states. The eye drops have been linked to a bacterial infection that is resistant to multiple types of antibiotics.

Dr. Michael Bell, Deputy Director of the Division of Healthcare Quality Promotion at the CDC, said in a statement: “We are concerned that this product may be linked to serious infections and one death. We are urging health care providers and patients to stop using the product immediately and to contact their health care provider if they have any symptoms of infection.”

The CDC is also warning that the infection could spread to other parts of the country if the eye drops are not disposed of properly. They are recommending that patients who have used the product seek medical attention if they experience any symptoms of infection, such as redness, swelling, pain, discharge, or blurred vision.

The EzriCare eye drops have been recalled in the United States and the manufacturer, Aurobindo Pharma, has issued a statement saying that it is “cooperating with the CDC and FDA to investigate this matter and ensure the safety of our products.”

The CDC is urging everyone to take precautions and to be aware of the potential risks associated with the eye drops.